Morgan Stanley analyst Michael Cyprys downgraded Cboe Global Markets (CBOE) to Underweight from Equal Weight with a $199 price target The firm believes the shares are pricing in high-single-digit to double-digit sales acceleration, but its work shows risks to Cboe’s growth and the valuation multiple. Cboe trades at 22-times Morgan Stanley’s 2026 earnings estimates, a 1-2 times premium to its historical averages and a 7% premium to peers averaging. It see downside risks saying the company’s decelerating growth could drive earnings misses, while a focus on margin stability and openness to acquisitions could lead to multiple contraction.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBOE:
- Cboe Global Markets reports October trading volume
- Cboe Global Markets price target lowered to $212 from $214 at Deutsche Bank
- Cboe Global Markets price target lowered to $232 from $237 at Oppenheimer
- Cboe Global Markets price target lowered to $230 from $239 at Barclays
- Cboe Global Markets Posts Strong Q3 2024 Results